Dual incretin signaling helps regulate appetite and increase satiety to support long-term weight management
Enhances insulin sensitivity and reduces post-meal glucose spikes to help maintain healthy glucose levels
Activates GLP-1 and GIP pathways that help coordinate appetite, cravings, and energy balance
Improved weight and metabolic control may help reduce risk factors associated with cardiometabolic disease
Tirzepatide activates two key metabolic hormone receptors—GLP-1 and GIP—that help regulate appetite, blood sugar, and cravings. By improving insulin sensitivity and slowing gastric emptying, tirzepatide helps the body better manage glucose levels while promoting feelings of fullness that can support sustainable weight loss.
Treatment may be provided as either a commercially available tirzepatide product or a compounded formulation prepared by a licensed compounding pharmacy, based on what your clinician determines is most appropriate for your care.
When provided as a compounded medication, tirzepatide is specially formulated with vitamin B12 and glycine, which helps maintain B12 levels and supports cellular energy production and metabolic health during treatment.
Pharmaceutical products are only available to members of the Lifeforce Membership ($149/month) and are contingent on blood tests results and clinician video consult. To qualify for the program you must reside in an eligible state* and purchase a Lifeforce Diagnostic ($599).

Prevent glucose spikes with a tablet that increases insulin sensitivity and disposes of excess glucose in the liver, muscle, fat, and brain.

A GLP-1 therapy that helps regulate appetite, improve blood sugar control, and support sustainable weight loss.

A compounded thyroid hormone therapy combining T4 and T3 in ratios to support balanced metabolism, energy production, and thyroid hormone signaling.

Fight age-related hormonal decline.